Australian & New Zealand Registry Of Advanced Glaucoma (ANZRAG)…..World-first discovery by ANZRAG team….
Glaucoma is the second most prevalent cause of blindness in the world (WHO) and can, in most cases, be prevented if those at high risk of developing the disease are identified and treated appropriately at an early stage. Many people at high risk of developing glaucoma are asymptomatic in the early stages, and so are not diagnosed until irreversible vision loss has occurred.
The Australian and New Zealand Registry of Advanced Glaucoma, established by Flinders University’s Professor Jamie Craig, aims to provide the world’s largest collection of advanced glaucoma cases, along with clinical information and DNA, to ascertain new, genetic glaucoma risk profiles. Better identification of those people at high risk of glaucoma, through genetic screening, would result in an overall reduction of preventable blindness by treating the condition before serious sight loss has occurred.Predicting genetic risk of glaucomaThe application of a polygenic risk score (PRS)  in predicting POAG risk has been a major success in the study of common diseases.Click HereGlaucoma Test “Best Yet”Read MoreScientists develop test that will help prevent glaucoma-related blindnessRead MoreGene discovery offers new line of defence against glaucomaClick Here

Why do we need a Glaucoma Registry?

To provide the world’s largest collection of advanced glaucoma cases, along with clinical information and DNA, to ascertain new, genetic glaucoma risk profiles.

Benefits

Better identification of those people at high risk of glaucoma, through genetic screening, would result in an overall reduction of preventable blindness by treating the condition before serious sight loss has occurred.

About our Projects

Predicting the genetic risk of glaucoma.
Congenital glaucoma.
Targeting at risk relatives of glaucoma patients for early diagnosis and treatment (TARRGET)




Would you like to refer a patient?

Download referral form and email us; or submit referral online.

Participants
0
Patients with Advanced Glaucoma
0
Average age at diagnosis
0

TARRGET
Targeting at risk relatives of glaucoma patients for early diagnosis & treatment.


TARRGET

More than 50% of close relatives of people with severe vision loss from glaucoma are at risk of developing glaucoma during their lifetime.

All donations to ANZRAG are gratefully accepted through Flinders University of SA.

Or contact the office via phone or email.

To donate online via the University, click on donate and select “Choose a specific fund” and “Australian & New Zealand Registry of Advanced Glaucoma Research Fund”.


Donate

Flinders University

Contact Us

About ANZRAG

CONTACT US

Information and Resources

ANZRAG NewslEtter

Subscribe to receive the latest news and updates.

Copyright 2026 Australia and New Zealand Registry of Advanced Glaucoma. All rights reserved.

Skip to content